The journey of a drug from the laboratory to the pharmacy is a complex and multifaceted process that involves several stages, including research and development, clinical trials, regulatory approval, and manufacturing. This article will provide an overview of the pharmaceutical pipeline, tracking the journey of a drug from lab to pharmacy.
Research and Development
The process of developing a new drug begins with basic research to identify potential drug targets and compounds that may have therapeutic effects. This is followed by preclinical research, in which the safety and efficacy of the drug candidate are evaluated in laboratory and animal studies. If the results of the preclinical research are promising, the drug candidate may proceed to clinical trials.
Clinical Trials
Clinical trials are conducted to evaluate the safety and efficacy of a drug in human subjects. These trials are typically conducted in three phases. Phase I trials are small studies that are designed to evaluate the safety of the drug and determine the appropriate dosage. Phase II trials are larger studies that are designed to evaluate the efficacy of the drug and further assess its safety. Phase III trials are even larger studies that are designed to confirm the efficacy and safety of the drug in a larger population.
Regulatory Approval
Once the results of the clinical trials have been analyzed, the drug developer can submit an application for regulatory approval to the appropriate government agency, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe. The regulatory agency will review the data from the clinical trials and determine whether the drug is safe and effective for its intended use. If the drug is approved, it can be marketed and sold to the public.
Manufacturing
Once a drug has been approved, it can be manufactured and distributed to pharmacies and other healthcare providers. The manufacturing process must be carefully controlled to ensure that the drug is of high quality and is free from contamination. The drug must also be packaged and labeled in accordance with regulatory requirements.
The journey of a drug from the laboratory to the pharmacy is a complex and time-consuming process that involves many different stages. It typically takes many years and costs millions of dollars to develop a new drug. However, the potential rewards are great, as successful drugs can improve the lives of millions of people and generate significant profits for their developers.
According to the Pharmaceutical Journal, the research and development journey of new drugs that make it to market will have taken around 12 years and cost around £1.15bn. The journey begins in a university laboratory where researchers, with grants from research bodies or the pharmaceutical industry, undertake basic research to understand the processes behind a disease, often at a cellular or molecular level. Once a potential target has been identified, researchers search for a molecule or compound that acts on this target. Historically, researchers have looked to natural products, such as plants, fungi, and bacteria, for new drug compounds. However, advances in technology have made it possible to design and create new drug compounds in the laboratory.
The clinical development of an investigational new drug follows a series of phases. Phase I studies help scientists understand the safety and correct dosing of an investigational medicine or vaccine. Phase II studies gather more information about safety and begin to understand how well a study treatment or vaccine works (efficacy). Phase III studies focus on safety, efficacy, and dosing in preparation for regulatory approval.
Once the drug product receives approval from the regulatory authority, numerous activities are initiated to prepare for product launch, including manufacturing scale-up. The FDA provides guidance on "advanced manufacturing," which is designed to improve drug quality, address shortages of medicines, and expedite time-to-market. Post-marketing safety surveillance involves monitoring a drug product's long-term safety and efficacy post-approval, when it has reached the market and is in wider use.
In conclusion, the pharmaceutical pipeline is a complex and lengthy process that involves research and development, clinical trials, regulatory approval, and manufacturing. The journey of a drug from the laboratory to the pharmacy typically takes many years and requires significant financial investment. However, the potential benefits of successfully bringing a new drug to market are substantial, both in terms of improving patient outcomes and generating financial returns for drug developers.
Author: Pooyan Ghamari, Swiss Economist & Visionary
LinkedIn
Instagram
Twitter
YouTube